In the functional service provider model, a company can outsource specific functions of clinical research while retaining control and increasing efficiency. We spoke to KPS Life founder and chief executive David Kelly and chief operating officer George Sawicki to learn more.
Ensuring equitable access to medicines is a key challenge for many governments, particularly those of smaller nations. Pharmaceutical Technology reviews the data and explores European initiatives to improve the situation.
The Nordics are a well-known powerhouse of pharmaceutical innovation and production. But what opportunities do the region’s own pharma markets offer industry players, and what do marketing authorisation holders need to know when bringing new medicines to these countries?